| Elizabeth C Harrel, MD | |
|
2300 Hospital Drive, Suite 400, Bossier City, LA 71111 | |
| (318) 212-7850 | |
| (318) 212-7858 |
| Full Name | Elizabeth C Harrel |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 21 Years |
| Location | 2300 Hospital Drive, Bossier City, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326257304 | NPI | - | NPPES |
| 06022 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 200162 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Willis Knighton Medical Center, Inc | Shreveport, LA | Hospital |
| Entity Name | Wkp Arklatex Urology Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801137906 PECOS PAC ID: 4880832914 Enrollment ID: O20130601000066 |
News Archive
GW researchers in the School of Medicine, Jeffrey M. Bethony, Ph.D., Associate Professor of Microbiology, Immunology, and Tropical Medicine and David Diemert, M.D., FRCP(C), Associate Research Professor of Microbiology, Immunology, and Tropical Medicine and Director of Clinical Trials for the Sabin Vaccine Institute's Product Development Partnership (PDP), have been awarded a Pilot Grant from the Clinical and Translational Science Institute-Children's National.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Purdue University researchers have reproduced portions of the female breast in a tiny slide-sized model dubbed "breast on-a-chip" that will be used to test nanomedical approaches for the detection and treatment of breast cancer.
According to a study released August 26, 2009 by the British Medical Journal, more than half of Hong Kong's healthcare workers surveyed said they would refuse the H1N1 shot, which is not yet available, because they are afraid of side effects and doubt how safe and effective it will be. More importantly, the study suggested the trend would be repeated worldwide.
Older adults who survived severe sepsis were more likely to develop substantial cognitive impairment and functional disability, according to a study in the October 27 issue of JAMA.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth C Harrel, MD 2300 Hospital Drive, Suite 400, Bossier City, LA 71111 Ph: (318) 212-7850 | Elizabeth C Harrel, MD 2300 Hospital Drive, Suite 400, Bossier City, LA 71111 Ph: (318) 212-7850 |
News Archive
GW researchers in the School of Medicine, Jeffrey M. Bethony, Ph.D., Associate Professor of Microbiology, Immunology, and Tropical Medicine and David Diemert, M.D., FRCP(C), Associate Research Professor of Microbiology, Immunology, and Tropical Medicine and Director of Clinical Trials for the Sabin Vaccine Institute's Product Development Partnership (PDP), have been awarded a Pilot Grant from the Clinical and Translational Science Institute-Children's National.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
Purdue University researchers have reproduced portions of the female breast in a tiny slide-sized model dubbed "breast on-a-chip" that will be used to test nanomedical approaches for the detection and treatment of breast cancer.
According to a study released August 26, 2009 by the British Medical Journal, more than half of Hong Kong's healthcare workers surveyed said they would refuse the H1N1 shot, which is not yet available, because they are afraid of side effects and doubt how safe and effective it will be. More importantly, the study suggested the trend would be repeated worldwide.
Older adults who survived severe sepsis were more likely to develop substantial cognitive impairment and functional disability, according to a study in the October 27 issue of JAMA.
› Verified 1 days ago
Dr. William Stewart Bundrick Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2449 Hospital Dr, Suite 280, Bossier City, LA 71111 Phone: 318-841-4004 Fax: 318-841-4008 | |
Gerard Dayle Henry, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2449 Hospital Dr, Ste 280, Bossier City, LA 71111 Phone: 318-212-7850 Fax: 318-841-4008 | |
Ezekiel Arthur Lopez, PA-C Urology Medicare: Medicare Enrolled Practice Location: 2449 Hospital Dr, Bossier City, LA 71111 Phone: 318-841-4004 | |
Christopher M. Wilson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2449 Hospital Dr, Suite 280, Bossier City, LA 71111 Phone: 318-841-4004 Fax: 318-841-4008 |